세계의 케타민 클리닉 시장 보고서(2025년)
Ketamine Clinic Global Market Report 2025
상품코드 : 1810931
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

케타민 클리닉 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 9.4%로 19억 달러로 성장합니다. 예측 기간 중 예상되는 성장은 치료 저항성 우울증의 유병률 증가, 불안장애 사례 증가, 외상 후 스트레스 장애 진단 증가, 만성 통증 상태의 높은 비율, 만성질환으로서의 정신건강 장애에 대한 인식의 확대 등에 기인합니다. 이 기간의 주요 동향으로는 케타민 보조 요법 스크리닝을 위한 원격의료의 부상, 주입 후 관리를 위한 원격 환자 모니터링 툴의 사용, 케타민 치료 중 기분 추적을 위한 모바일 앱 개발, 전자건강기록과 케타민 치료 프로토콜의 통합, 치료에 적합한 후보자를 식별하기 위한 AI 지원 툴의 도입 등이 있습니다. AI 지원 툴의 도입 등이 있습니다.

정신건강 장애의 유병률 증가는 향후 수년간 케타민 클리닉 시장의 성장을 가속할 것으로 예측됩니다. 정신건강 장애에는 일상적인 기능이나 사회적 관계에 영향을 미칠 수 있는 감정, 사고, 행동의 장애가 포함됩니다. 정신건강 문제 증가의 주요 요인 중 하나는 사회적 고립의 확대이며, 인적 교류와 지원의 감소로 인해 정서적, 심리적 스트레스가 증가합니다. 케타민 클리닉은 불안과 우울증의 증상을 완화하는 즉각적인 치료를 제공하여 이러한 상태가 더 심각한 정신건강 문제로 발전하는 것을 방지합니다. 예를 들어 2025년 6월 미국 정부 기관인 질병통제예방센터는 2022-2023년 사이에 3세에서 17세 사이의 어린이 중 11%가 불안증 진단을 받았으며, 남자아이는 9%, 여자아이는 12%, 행동장애는 8%, 남자아이는 10%, 여자아이는 5%가 불안장애를 앓고 있다고 보고했습니다. 따라서 정신건강 상태의 발생률이 증가함에 따라 케타민 클리닉 시장이 발전하고 있습니다.

케타민 클리닉 시장의 주요 기업은 증거 기반 치료법과 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 근거 기반 치료법은 일관된 치료 결과를 보장하기 위해 입증된 체계적인 연구와 임상 연구에 의존하고 있습니다. 증거 기반 치료는 특정 심리학적 또는 행동학적 문제를 해결하기 위해 사용되는 과학적으로 검증된 접근법입니다. 예를 들어 2025년 6월 미국의 정신건강 서비스 제공 업체인 Rooted Rhythm Therapy는 미국의 케타민 보조 심리치료 업체인 Noma Therapy와 제휴하여 보험이 적용되는 케타민 치료 프로그램을 시작했습니다. 우울증, 불안, 소진, 트라우마에 직면한 부모를 위한 전문 심리치료와 전문가의 소마틱 케어가 결합된 프로그램입니다. 이 프로그램에는 노마의 케타민 보조요법, 임상지도, 루츠 리듬의 부모를 중심으로 한 교육적, 정신적 지원이 통합되어 있습니다. 치료에는 보험이 적용되는 케타민 치료, 전문가의 투약 및 복약 관리, 감정 조절, 소마틱 기법, 가족 친화적인 스케줄 설정에 초점을 맞춘 개인 및 그룹 치료 등이 포함됩니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

A ketamine clinic is a specialized healthcare facility focused on administering and overseeing ketamine treatments in a controlled, professional environment. These clinics are staffed by licensed medical professionals and follow strict regulatory and safety protocols. They provide a secure setting to ensure accurate dosing, patient monitoring, and effective risk management.

The primary therapy options at ketamine clinics include online therapy and on-site therapy. Online therapy utilizes digital platforms to offer mental health support via video calls, chat, or virtual consultations. This approach treats conditions such as anxiety, depression, post-traumatic stress disorder (PTSD), and more, drawing referrals from primary care physicians, online marketing, and mental health specialists. Ketamine administration methods include injectable forms, nasal sprays, and oral tablets. The treatment serves various end users, including individuals, hospitals and clinics, specialized ketamine centers, and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The ketamine clinic market research report is one of a series of new reports from The Business Research Company that provides ketamine clinic market statistics, including ketamine clinic industry global market size, regional shares, competitors with a ketamine clinic market share, detailed ketamine clinic market segments, market trends and opportunities, and any further data you may need to thrive in the ketamine clinic industry. This ketamine clinic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ketamine clinic market size has grown strongly in recent years. It will grow from $1.21 billion in 2024 to $1.32 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period can be attributed to the increasing demand for alternative mental health treatments, the expansion of mental health treatment centers, growth in outpatient infusion clinics, a rise in out-of-pocket spending on mental health care, and improved affordability of generic ketamine.

The ketamine clinic market size is expected to see strong growth in the next few years. It will grow to $1.90 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth projected for the forecast period can be attributed to the increasing prevalence of treatment-resistant depression, rising cases of anxiety disorders, growing diagnoses of post-traumatic stress disorder, high rates of chronic pain conditions, and the expanding recognition of mental health disorders as chronic illnesses. Key trends during this period include the rise of telemedicine for ketamine-assisted therapy screening, the use of remote patient monitoring tools for post-infusion care, the development of mobile apps for mood tracking during ketamine treatment, integration of electronic medical records with ketamine therapy protocols, and the implementation of AI-enabled tools to identify suitable candidates for treatment.

The rising prevalence of mental health disorders is anticipated to drive the growth of the ketamine clinic market in the coming years. Mental health disorders involve disturbances in emotions, thinking, or behavior that can affect daily functioning and social relationships. One key contributor to the increase in mental health issues is growing social isolation, which leads to heightened emotional and psychological stress due to reduced human interaction and support. Ketamine clinics provide rapid-acting treatments that help alleviate symptoms of anxiety and depression, preventing these conditions from escalating into more severe mental health problems. For example, in June 2025, the Centers for Disease Control and Prevention, a US government agency, reported that between 2022 and 2023, 11% of children aged 3 to 17 were diagnosed with anxiety, 9% for boys and 12% for girls, while 8% had behavioral disorders, affecting 10% of boys and 5% of girls. Hence, the growing incidence of mental health conditions is propelling the ketamine clinic market forward.

Leading companies in the ketamine clinic market are concentrating on developing innovative solutions, such as evidence-based therapies, which rely on proven, systematic research and clinical studies to ensure consistent treatment outcomes. Evidence-based therapies are scientifically validated approaches used to address specific psychological or behavioral issues. For instance, in June 2025, Rooted Rhythm Therapy, a US mental health service provider, partnered with Noma Therapy, a US ketamine-assisted psychotherapy provider, to launch an insurance-covered ketamine therapy program. This initiative combines expert somatic care with professional psychotherapy tailored specifically for parents facing depression, anxiety, burnout, or trauma. The program integrates ketamine-assisted therapy from Noma, clinical guidance, and Rooted Rhythm's parent-centered educational and emotional support. Services include ketamine treatment covered by insurance, along with professional dosing and medication management, as well as individual and group therapy focused on emotional regulation, somatic techniques, and family-friendly scheduling.

In February 2024, Ketamine Wellness Clinic of Orange County, a US-based ketamine therapy provider, acquired Mind Space Ketamine Infusion Clinic for an undisclosed sum. This acquisition expands the combined clinics' treatment offerings for mood and pain-related conditions. It also aims to enhance patient care across Laguna Beach and the wider Orange County region by introducing more advanced ketamine therapy methods. Mind Space Ketamine Infusion Clinic is a US-based ketamine treatment provider.

Major players in the ketamine clinic market are Mindbloom Inc., Mindful Health Solutions, Neuro Wellness Spa, The Ketamine Clinic, Clarity Clinic, Revitalist Lifestyle and Wellness Ltd., Nushama, Innerwell, Klarisana Health, NY Ketamine Infusions, Axon Therapies Inc., Alleviant Health Centers, Lone Peak Psychiatry, MindPeace Clinics, NeuroRelief Ketamine & Infusion Therapy, Choose Your Horizon Inc., Innerbloom Ketamine Therapy, Viking Psychiatry, Norcal Ketamine Infusion Centers, and Pacific KLN Infusions.

North America was the largest region in the ketamine clinic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in ketamine clinic report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the ketamine clinic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ketamine clinic market includes revenues earned by entities by administration services, pre- and post-session support, progress tracking, and vital sign monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ketamine Clinic Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ketamine clinic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for ketamine clinic ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ketamine clinic market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Ketamine Clinic Market Characteristics

3. Ketamine Clinic Market Trends And Strategies

4. Ketamine Clinic Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Ketamine Clinic Growth Analysis And Strategic Analysis Framework

6. Ketamine Clinic Market Segmentation

7. Ketamine Clinic Market Regional And Country Analysis

8. Asia-Pacific Ketamine Clinic Market

9. China Ketamine Clinic Market

10. India Ketamine Clinic Market

11. Japan Ketamine Clinic Market

12. Australia Ketamine Clinic Market

13. Indonesia Ketamine Clinic Market

14. South Korea Ketamine Clinic Market

15. Western Europe Ketamine Clinic Market

16. UK Ketamine Clinic Market

17. Germany Ketamine Clinic Market

18. France Ketamine Clinic Market

19. Italy Ketamine Clinic Market

20. Spain Ketamine Clinic Market

21. Eastern Europe Ketamine Clinic Market

22. Russia Ketamine Clinic Market

23. North America Ketamine Clinic Market

24. USA Ketamine Clinic Market

25. Canada Ketamine Clinic Market

26. South America Ketamine Clinic Market

27. Brazil Ketamine Clinic Market

28. Middle East Ketamine Clinic Market

29. Africa Ketamine Clinic Market

30. Ketamine Clinic Market Competitive Landscape And Company Profiles

31. Ketamine Clinic Market Other Major And Innovative Companies

32. Global Ketamine Clinic Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ketamine Clinic Market

34. Recent Developments In The Ketamine Clinic Market

35. Ketamine Clinic Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기